Liquid biopsy in early stage lung cancer

Lung cancer is the leading cause of cancer-associated deaths worldwide. Surgery is the standard treatment for early-stage non-small cell lung cancer (NSCLC). However, 30% to 80% of these patients will die within 5 yearS of diagnosis. Circulating cell-free DNA (cfDNA) harbors pathologic characteristi...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Transl Lung Cancer Res
Hoofdauteurs: Pérez-Ramírez, Cristina, Cañadas-Garre, Marisa, Robles, Ana I., Molina, Miguel Ángel, Faus-Dáder, María José, Calleja-Hernández, Miguel Ángel
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: AME Publishing Company 2016
Onderwerpen:
Review Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5099510/
https://ncbi.nlm.nih.gov/pubmed/27826533
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr.2016.10.15
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items